Immix Biopharma
IMMX
#9303
Rank
HK$0.46 B
Marketcap
HK$16.86
Share price
-2.25%
Change (1 day)
-69.97%
Change (1 year)

Earnings for Immix Biopharma (IMMX)

Earnings in 2024 (TTM): -HK$0.18 Billion

According to Immix Biopharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$0.13 Billion a decrease over its 2022 earnings that were of -HK$63.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immix Biopharma from 2021 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.18 Billion44.1%
2023 -HK$0.13 Billion93.61%
2022 -HK$63.87 Million-66.03%
2021 -HK$0.19 Billion